DerickEVergneMD

PubMed

• 11 citations
  International prescribing patterns for mood illness: The international mood network (IMN)
  Sivan Mauer, Rami Alahmari, Paul A. Vöhringer, Derick E. Vergne, H. Lövdahl, Eduardo Correa, Ashwin A. Patkar, Chi-Un Pae, S. Strejilevich, Shannon Dalley, S. Nassir G...> ;Journal of Affective Disorders. 2014 Oct 1
• 31 citations
  Standard and trace-dose lithium: A systematic review of dementia prevention and other behavioral benefits
  Sivan Mauer, Derick E. Vergne, S. Nassir Ghaemi> ;The Australian and New Zealand Journal of Psychiatry. 2014 Jun 11
• 102 citations
  Cognitive impairment in bipolar disorder and schizophrenia: a systematic review.
  Paul A. Vöhringer, Sergio Barroilhet, Andrea Amerio, Maria Laura Reale, Katherine Alvear, Derick E. Vergne, S. Nassir Ghaemi> ;Frontiers in Psychiatry. 2013 Aug 8
• 20 citations
  Effectiveness of short-term olanzapine in patients with bipolar I disorder, with or without comorbidity with substance use disorder
  Gabriele Sani, Georgios D. Kotzalidis, Paul A. Vöhringer, Daniela Pucci, Alessio Simonetti, Giovanni Manfredi, Valeria Savoja, Stefano Maria Tamorri, Lorenzo Mazzarini...> ;Journal of Clinical Psychopharmacology. 2013 Apr 1
• 24 citations
  The varieties of depressive experience: diagnosing mood disorders.
  S. Nassir Ghaemi, Paul A. Vöhringer, Derick E. Vergne> ;The Psychiatric Clinics of North America. 2012 Mar 1
• 27 citations
  Aripiprazole: a drug with a novel mechanism of action and possible efficacy for alcohol dependence.
  Derick E. Vergne, Raymond F Anton> ;CNS & Neurological Disorders Drug Targets. 2010 Feb 28
• 33 citations
  The interaction of serotonin transporter gene polymorphisms and early adverse life events on vulnerability for major depression
  Derick E. Vergne, Charles B. Nemeroff> ;Current Psychiatry Reports. 2006 Dec 1
• 26 citations
  Cembranoid and long-chain alkanol sites on the nicotinic acetylcholine receptor and their allosteric interaction.
  Oné R. Pagán, Vesna A. Eterovic, Miosotis Garcia, Derick Vergne, Carlos M. Basilio, and Abimael D. Rodríguez, Richard M. Hann> ;Biochemistry. 2001 Sep 18
• Join now to see all

Journal Articles

• Apathy, Explained  
  Vergne DE, Medscape, 1/16/2016
• The Biology of Borderline (and a Diagnostic Tip)  
  Vergne DE, Medscape, 1/23/2015
• Menstrual Psychosis: A Forgotten Disorder?  
  Roberta Zanzonico, Derick E. Vergne, Medscape, 1/21/2015
• Modafinil for Alcohol Dependence: In Search of Solutions to an Epidemic  
  Vergne DE, Medscape, 1/25/2014
• How the Brain Responds to Trauma  
  Vergne DE, Medscape, 1/24/2014
• What Is Addiction?  
  Vergne DE, Medscape, 1/22/2014
• Dopamine in Psychosis: Are We on the Right Path?  
  Vergne DE, Medscape, 1/21/2014
• Can Regret Help Identify Mood Disorders?  
  Vergne DE, Medscape, 1/20/2014
• Toward a 'Where' and 'How' Understanding of Dopamine Dysfunction in Disorders of Attention  
  Vergne DE, Medscape, 1/11/2014
• Understanding Inattention: Diagnosis and Misdiagnosis  
  Vergne DE, Medscape, 1/11/2014
• International Prescribing Patterns for Mood Illness: The International Mood Network (IMN)  
  Sivan Mauer, Rami Alahmari, Paul A. Vöhringer, Derick E. Vergne, H. Lövdahl, E. Correa, A. Patkar, C. Pae, S. Strejilevich, S. Dalley, S. Nassir Ghaemi J, Affect Disord, 1/2/2014
• Effectiveness of Short-Term Olanzapine in Patients With Bipolar-I Disorder, With or Without Comorbidity With Substance Use Disorder  
  Gabriele Sani, MD, Georgios D. Kotzalidis, MD, Paul Vo¨hringer, MD, Daniela Pucci, MD, Alessio Simonetti, MD, Giovanni Manfredi, MD, Valeria Savoja, MD, PhD, Stefano M..., Journal of Clinical Psychopharmacology, 1/1/2013
• The Varieties of Depressive Experience: Diagnosing Mood Disorders  
  S. Nassir Ghaemi, MD, Paul A. Vöhringer, MD; Derick E. Vergne, MD, Psychiatric Clinics of North America, 1/1/2012
• Adult ADHD and amphetamines: a new paradigm  
  Derick E Vergne, Elizabeth A Whitham, Sergio Barroilhet, Yuli Fradkin, & S Nassir Ghaemi, Neuropsychiatry, 1/1/2011
• Aripiprazole: A drug with a novel mechanism of action and possible efficacy for alcohol dependence  
  Vergne DE & Anton RF, CNS & Neurological Disorders Drug Targets, 1/1/2010
• Alcohol Cue- Induced Activation of Ventral Striatum is Related to Alcohol-Induced Stimulation in Humans: Aripiprazole Effects  
  Raymond F. Anton, Hugh Myrick, Konstantin Voronin, Patrick K. Randall, Abraham Tiffany, Scott Henderson, Xingbao Li, Derick E. Vergne, Alcoholism: Clinical & Experimental Research, 1/1/2010
• OPRM1 Genotype, Alcohol Consumption/effects, and Naltrexone Response under Natural Conditions and in a Bar-Lab Paradigm  
  R.F. Anton, K. Voronin, H. Myrick, P.K. Randall, A. Tiffany, D.E.Vergne, Alcoholism: Clinical & Experimental Research, 1/1/2010
• The interaction of serotonin transporter gene polymorphisms and early adverse life events on vulnerability for major depression  
  Vergne DE & Nemeroff CB, Current Psychiatry Report, 1/1/2006
• Neuropeptide Y (rs16740) Single Nucleotide Polymorphism Moderates the Effects of Anxiety on Alcohol Drinking in Early Stage Alcoholics  
  D.E. Vergne, R.F. Anton, K. Voronin, A. Tiffany, H. Myrick, C. Canders, G. Klaybor, P.K. Randall, Alcoholism: Clinical & Experimental Research
• Join now to see all

Abstracts/Posters

• Clinical Predictive Features of Substance Abuse in Mood Disorders: An International Study Data from the International Mood Network (IMN)
  Derick E Vergne, MD, Paul A. Vöhringer, MD; Niki S. Holtzman, BA; Matthew C. Sullivan, BA; S. Nassir Ghaemi, MD, MPH for the IMN Investigators, Annual Meeting of the American Psychiatric Association, 1/1/2012
• Neuropeptide Y rs16147 Single Nucleotide Polymorphism is associated with heavy drinking Severity of alcohol dependence
  Derick E. Vergne, Raymond F. Anton, Konstantin Voronin, Abraham Tiffany, Caleb Canders, Garrick Klaybor, Patrick Randall, Joe Schacht, Guze Symposium on Alcoholism Disentangling the Genetics of Alcoholism: Understanding Pathophysiology and Improving Treatment, 1/1/2010
• Neuropeptide Y (rs16740) Single Nucleotide Polymorphism Moderates the Effects of Anxiety on Alcohol Drinking in Early Stage Alcoholics
  D.E. Vergne, R.F. Anton, K. Voronin, A. Tiffany, H. Myrick, C. Canders, G. Klaybor, P.K. Randall, Alcoholism: Clinical & Experimental Research, Annual Research Society for Alcoholism symposium, San Antonio, TX, 1/1/2010
• Dopamine Transporter Genes are Related to Drinking in Early Stage Alcohol Dependent Individuals: Effects of Naltrexone?
  Raymond F. Anton, Derick Vergne, Konstantin Voronin, Patrick Randall, Abraham Tiffany, Garrick Klaybor, Melanie McMillan, International Society for Psychiatric Genetics Annual Meeting, Athens, Greece, 1/1/2010
• Alcohol Cue-Induced Activation of Ventral Striatum is Related to Alcohol-Induced Stimulation in Humans: Aripiprazole Effects
  Raymond F. Anton, Hugh Myrick, Konstantin Voronin, Patrick K. Randall, Abraham Tiffany, Scott Henderson, Xingbao Li, Derick E. Vergne, Alcoholism: Clinical & Experimental Research: Annual Research Society for Alcoholism Symposium, San Antonio, TX, 1/1/2010
• OPRM1 Genotype, Alcohol Consumption/effects, and Naltrexone Response under Natural Conditions and in a Bar-Lab Paradigm
  R.F. Anton K. Voronin, H. Myrick, P.K. Randall, A. Tiffany, D.E. Vergne, Alcoholism: Clinical & Experimental Research, Annual Research Society for Alcoholism symposium, San Antonio, TX, 1/1/2010
• Dopamine Transporter Genetic Differences are Related to Drinking and Craving in Early Stage Alcohol Dependent Individuals
  Raymond Anton, Konstantin Voronin, Derick Vergne, Abraham Tiffany, Garrick Klaybor, Caleb Canders, Patrick Randall, ACNP Annual Meeting, Ft. Lauderdale FL, 1/1/2009
• Association between NPY mRNA expression in The hypothalamus of rats and the prepulse Inhibition of the startle
  D. Vergne, R. Caceda, B. Kinkead, M. Owens CB Nemeroff, Research Colloquium for Junior Investigators American Psychiatric Association (APA) meeting, Toronto, Canada, 1/1/2006
• Join now to see all